Viewing data from:

CHORIONIC GONADOTROPIN

BLA

GONADOTROPIN, CHORIONIC | B017067 | FRESENIUS KABI USA

4 products0 Purple Book patents

Biologic LOENo LOE data

No exclusivity dates or listed patents found in Purple Book

Purple Book Patents

No listed patents in Purple Book.

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

Purple Book (Biologics)

BLA 17067 | 4 presentations

351(a) ReferenceLicensedCDERFor Injection

Proper Name

chorionic gonadotropin

Applicant

Fresenius Kabi USA, LLC

Approval Date

5-Mar-73

Presentations

5,000UNITS — Multi-Dose Vial (Intramuscular)

10,000UNITS — Multi-Dose Vial (Intramuscular)

15,0000UNITS — Multi-Dose Vial (Intramuscular)

20,000UNITS — Multi-Dose Vial (Intramuscular)

Source: FDA Purple Book (purplebooksearch.fda.gov).

Approval Letters

2 letters from Drugs@FDA

Date	Submission	Document
Oct 3, 2023	SUPPL -66	View Letter (PDF)
Mar 23, 2020	SUPPL -57	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (4)

Sort:

#001 — 5,000 UNITS/VIAL

▴

INJECTABLE;INJECTION | Approved: 1973-03-05 00:00:00

No patent or exclusivity listings for this strength.

#002 — 10,000 UNITS/VIAL

▾

INJECTABLE;INJECTION | Approved: 1973-03-05 00:00:00

#003 — 20,000 UNITS/VIAL

▾

INJECTABLE;INJECTION | Approved: 1973-03-05 00:00:00

#004 — 15,000 UNITS/VIAL

▾

INJECTABLE;INJECTION | Approved: 1973-03-05 00:00:00